(Diethylamino)sulfur trifluoride → HCID 59149784, compound
Reaction equation
C(N(S(F)(F)[F:7])CC)C.[F:10][C:11]([F:33])([F:32])[C:12]1[N:16]2[N:17]=[C:18]([N:21]3[CH2:26][CH2:25][CH:24]([CH2:27][O:28][CH2:29][CH2:30]O)[CH2:23][CH2:22]3)[CH:19]=[CH:20][C:15]2=[N:14][N:13]=1>C(Cl)Cl>[F:7][CH2:30][CH2:29][O:28][CH2:27][CH:24]1[CH2:25][CH2:26][N:21]([C:18]2[CH:19]=[CH:20][C:15]3[N:16]([C:12]([C:11]([F:33])([F:32])[F:10])=[N:13][N:14]=3)[N:17]=2)[CH2:22][CH2:23]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(Diethylamino)sulfur trifluoride (0.059 mL, 0.45 mmol) was added dropwise to a stirred solution of 2-[[1-(3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl)methoxy]ethanol (104 mg, 0.3 mmol) in DCM (3 mL) at −70° C. The solution was allowed to warm to ambient temperature and stir for 18 hours. The solution was diluted with DCM and washed with 2M aqueous K2CO3. The organic phase was dried over MgSO4 and evaporated. The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5μ silica, 19 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 1% ammonia) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford 6-[4-[(2-fluoroethoxy)methyl]piperidin-1-yl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine (22.0 mg, 21%) as a white solid.
Workup
- washwashed with 2M aqueous K2CO3
- dry with materialThe organic phase was dried over MgSO4
- customevaporated
- customThe crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5μ silica, 19 mm diameter, 100 mm length)
- additionFractions containing the desired compound
- customwere evaporated to dryness
Sources & evidence
- ORD record
- ord-a1b3681539854ce49b6fb10a3f2f0f52
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003649B2
Reaction notes
Loading…